Does the Diacutaneous Fibrolysis Change Ultrasonographic Measurements in Patients With Carpal Tunnel Syndrome?
1 other identifier
interventional
60
1 country
1
Brief Summary
The carpal tunnel syndrome (CTS) is a common entrapment neuropathy caused by compression of the median nerve at the wrist.Clinically electroneuphysiological assessment is not accessible to all clinicians. In this way ultrasounds (US) is a more accessible and economical tool and many studies have reported that US has high sensitivity and specificity in the diagnosis of CTS.Diacutaneous Fibrolysis (DF) is a physiotherapeutic technique derived from Cyriax deep friction massage principles.DF technique could assist in improving changes in the connective tissues adjacent to the median nerve, especially the thickness of TCL and this could be reflected in a decreasing of TCL. Moreover, the neurophysiological and mechanical effect described by this technique may improve the nerve compression decreasing the CSA of the median nerve. The purpose of this study is to quantify changes in the cross-sectional area of the median nerve in the carpal tunnel and the thickness of transversal carpal ligament measured by US and the changes in the intensity of the numbness and the subjective assessment of clinical change after DF treatment in forearm, wrist and hand area compared to placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2021
CompletedStudy Start
First participant enrolled
February 10, 2021
CompletedFirst Posted
Study publicly available on registry
February 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2021
CompletedJanuary 18, 2022
January 1, 2022
3 months
February 10, 2021
January 14, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Cross sectional area of the median nerve with ultrasonography
Cross sectional area of the median nerve with ultrasonography at carpal tunnel level
Baseline (Before the treatment)
Cross sectional area of the median nerve with ultrasonography
Cross sectional area of the median nerve with ultrasonography at carpal tunnel level
After treatment application, an average of 2 weeks
Secondary Outcomes (5)
Intensity of numbness with the Visual Analogue Scale (VAS 1-10cm)
Baseline (Before the treatment)
Intensity of numbness with the Visual Analogue Scale (VAS 1-10cm)
After treatment application, an average of 2 weeks
Thicknesses of transverse carpal ligament with ultrasonography
Baseline (Before the treatment)
Thicknesses of transverse carpal ligament with ultrasonography
After treatment application, an average of 2 weeks
Subjective assessment of clinical change with the Global Rating of Change Scale (GROC Scale)
After treatment application, an average of 2 weeks
Study Arms (2)
Actual Diacutaneous Fibrolysis
EXPERIMENTALDiacutaneous Fibrolysis is a non invasive physiotherapeutic technique applied by means of a set of metallic hooks ending a spatula with bevelled edges that help to treat the muscles and conjunctive tissues and trying to improve mobility between mobility between muscle planes.
Sham Diacutaneous Fibrolysis
SHAM COMPARATORSham Diacutaneous Fibrolysis is applied at a superficial level. A pinch of skin was held with the thumb of the palpatory hand and the tip of the spatula but without effect in the muscle because no penetrate in deep tissue
Interventions
Diacutaneous Fibrolysis is a non invasive physiotherapeutic technique applied by means of a set of metallic hooks ending a spatula with bevelled edges that help to treat the muscles and conjunctive tissues and trying to improve mobility between mobility between muscle planes.
Eligibility Criteria
You may qualify if:
- \- Diagnosed medically with neurophysiological test of carpal tunnel syndrome (low and moderate intensity)
You may not qualify if:
- Severe carpal tunnel syndrome
- Previous surgery on the hand
- hormonal factors: diabetes, thyroids pathologies, pregnant
- Cervical disfunctions
- Ulcerations or skins disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sandra Jiménez Jiménez-del-Barrio
Soria, 42004, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra Jiménez-del-Barrio, PhD
University of Valladolid
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Physiotherapist
Study Record Dates
First Submitted
February 10, 2021
First Posted
February 21, 2021
Study Start
February 10, 2021
Primary Completion
May 20, 2021
Study Completion
July 10, 2021
Last Updated
January 18, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share